Cdc2-Cyclin B, the protein kinase that catalyzes the onset of mitosis, is subject to multiple forms of regulation. In the fission yeast Schizosaccharomyces pombe and most other species, a key mode of Cdc2-Cyclin B regulation is the inhibitory phosphorylation of Cdc2 on tyrosine-15. This phosphorylation is catalyzed by the protein kinases Wee1 and Mik1 and removed by the phosphatase Cdc25. These proteins are also regulated, a notable example being the inhibition of Wee1 by the protein kinase Nim1/Cdr1. The temperaturesensitive mutation cdc25-22 is synthetic lethal with nim1/cdr1 mutations, suggesting that a synthetic lethal genetic screen could be used to identify novel mitotic regulators. Here we describe that such a screen has identified cdr2 ϩ , a gene that has an important role in the mitotic control. Cdr2 is a 775 amino acid protein kinase that is closely related to Nim1 and mitotic control proteins in budding yeast. Deletion of cdr2 causes a G2-M delay that is more severe than that caused by nim1/cdr1 mutations. Genetic studies are consistent with a model in which Cdr2 negatively regulates Wee1. This model is supported by experiments showing that Cdr2 associates with the N-terminal regulatory domain of Wee1 in cell lysates and phosphorylates Wee1 in vitro. Thus, Cdr2 is a novel mitotic control protein that appears to regulate Wee1.
INTRODUCTION
In eukaryotic organisms the onset of mitosis is brought about by a protein kinase consisting of Cdc2 and Cyclin B. Cdc2 is the catalytic subunit, whereas Cyclin B is an essential regulatory component. The onset of mitosis marks a major transition in the cell cycle, involving a commitment to complete the cycle and undergo cell division. Thus, it is perhaps not surprising that Cdc2-Cyclin B is subjected to many forms of regulation. For example, in the fission yeast Schizosaccharomyces pombe, the timing of the onset of mitosis determines cell size; thus the mechanism that controls activation of Cdc2-Cyclin B is apparently able to sense cell size. Similarly, checkpoint controls that monitor DNA replication and repair regulate the activation of Cdc2-Cyclin B (Enoch and Nurse, 1990; Rhind et al., 1997; Rhind and Russell, 1998) . These checkpoints ensure that DNA is fully replicated and repaired before the onset of mitosis.
Much effort has been devoted to understanding how the activity of Cdc2-Cyclin B is regulated. In the fission yeast there appear to be at least four major mechanisms of regulating Cdc2-Cyclin B. The first involves the degradation of Cdc13, the major B-type cyclin in S. pombe. Cdc13 is specifically proteolyzed after exit from the mitotic (M) phase of the cell cycle (Yamano et al., 1996) . The second mechanism involves the protein Rum1, which binds and inhibits Cdc2-Cdc13 (CorreaBordes and Nurse, 1995) . Rum1 is important for regulating Cdc2-Cdc13 during G1 phase in cells that are attempting to undergo mating or meiosis (Moreno and Nurse, 1994) . The third mechanism involves phosphorylation of Cdc2 on threonine-167. This phosphorylation is required for Cdc2-Cdc13 protein kinase activity (Gould et al., 1991) . Phosphorylation of threonine-167 does not appear to change during the cell cycle; thus it may not have an important role in regulating the cell cycle. The fourth mechanism of regulating Cdc2-Cdc13 involves the phosphorylation of Cdc2 on tyrosine-15 (Gould and Nurse, 1989 ). This phosphorylation is inhibitory and appears to play a crucial role in the cell size and checkpoint mechanisms mentioned above.
In fission yeast, phosphorylation of Cdc2 on tyrosine-15 is catalyzed by the protein kinases Wee1 and Mik1. Inactivation of Wee1 causes a wee phenotype. Thus the temperature-sensitive wee1-50 mutation cause cells incubated at 35°C to divide at a cell length of ϳ7.5 m, approximately half the size of wild-type cells (Russell and Nurse, 1987a) . Inactivation of Mik1 has no effect on cell size, but simultaneous inactivation of Wee1 and Mik1 causes a lethal premature mitosis phenotype in which mitosis is initiated before DNA replication is complete (Lundgren et al., 1991) . Tyrosine-15 on Cdc2 is dephosphorylated by the phosphatases Cdc25 and Pyp3. Cdc25 contributes the major activity that dephosphorylates tyrosine-15 (Millar et al., 1991) . Cdc25 is normally essential for mitosis, although wee1 cdc25 cells are viable. Pyp3 is required for mitotic induction in a wee1 cdc25 background (Millar et al., 1992) .
There appear to be multiple mechanisms for modulating the protein kinases and phosphatases that regulate phosphorylation of Cdc2 on tyrosine-15. Cdc25 is activated by phosphorylation in M phase (Izumi et al., 1992; Kumagai and Dunphy, 1992; Hoffmann et al., 1993; Kovelman and Russell, 1996) . The identities of the protein kinases that activate Cdc25 are uncertain, but in vitro studies suggest that Cdc2-Cyclin B and members of the Polo kinase family are directly involved (Hoffmann et al., 1993; Izumi and Maller, 1993; Kuang et al., 1994; Kumagai and Dunphy, 1996; Descombes and Nigg, 1998) . It is thought that the activation of Cdc25 plays an important role in a positive feedback loop that is required for the induction of mitosis, although this hypothesis remains to be proven. Cdc25 also appears to be negatively regulated by Chk1, a protein kinase that is required for the repair checkpoint in fission yeast . Recently, the peptidyl-prolyl isomerase Pin1 was shown to bind and inhibit phosphorylated Cdc25 in human cells and Xenopus egg extracts (Crenshaw et al., 1998; Shen et al., 1998) , suggesting a possible role for Pin1 in the mitotic control.
Wee1 and Mik1 are also regulated by multiple mechanisms. Studies of Wee1 in human cells and Xenopus egg extracts have shown that Wee1 is inhibited by phosphorylation during M phase (McGowan and Russell, 1995; Mueller et al., 1995; Watanabe et al., 1995) . This regulation might also be part of a positive feedback loop to activate Cdc2-Cyclin B at the transition from G2 to M. Wee1 and Mik1 appear to also be regulated by the replication checkpoint that couples the onset of mitosis with the completion of DNA synthesis (Boddy et al., 1998) . Thus Cds1, a protein kinase that is activated by the replication checkpoint, associates with and phosphorylates Wee1 in cell lysates. Cds1 is also required for the large increase in the amount of Mik1 that occurs in cells arrested by the replication checkpoint.
In fission yeast, Wee1 is inhibited by the protein kinase Nim1 (Russell and Nurse, 1987b; Coleman et al., 1993; Parker et al., 1993; Wu and Russell, 1993) . Deletion of nim1 ϩ causes a cell elongation phenotype that is suppressed by wee1 mutations. Overproduction of Nim1 causes a wee phenotype that is not additive with wee1 mutations but causes lethal premature mitosis in mik1 cells (Lundgren et al., 1991) . These data argue strongly that Wee1 is the sole target of Nim1. Recently, the nif1 ϩ gene was isolated as a gene encoding a protein that physically interacts with Nim1 (Wu and Russell, 1997a) . Nif1 is thought to bind and inhibit Nim1 kinase.
Recent studies of fission yeast have revealed that stress-activated protein kinases also influence the mitotic control. Spc1/StyI is a protein kinase that is activated by Wis1 that in turn is activated by Wis4/ Wik1/Wak1 (Warbrick and Fantes, 1991; Millar et al., 1995; Shiozaki and Russell, 1995; Samejima et al., 1997; Shieh et al., 1997; . This protein kinase cascade is activated by many forms of stress, including osmotic, heat, and oxidative stress, as well as nutrient limitation (Degols et al., 1995; Degols and Russell, 1997) . Mutants that lack elements of this pathway are quite sensitive to stress-induced killing. These mutants are also delayed at the G2-M transition, exhibiting a cell elongation phenotype that is exaggerated by stress . In fact, spc1 or wis1 mutations exhibit a synthetic lethal phenotype when combined with the temperature-sensitive cdc25-22 mutation. Thus, cdc25-22 cells divide at a moderately elongated cell length at 25°C, whereas spc1 cdc25-22 or wis1 cdc25-22 cells undergo cell cycle arrest at 25°C. Curiously, spc1 cdc25-22 wee1-50 cells are inviable at 35°C, whereas cdc25-22 wee1-50 cells are viable at this temperature. Thus, Spc1 is able to influence the mitotic control independently of Cdc25 and Wee1.
Mutations of a number of important genes have synthetic lethal interactions with cdc25-22 at 25°C. These include null mutations of nim1 and spc1 as well as the temperature-sensitive cdc13-117 mutation (Russell and Nurse, 1987b; Shiozaki and Russell, 1995; our unpublished data) . Therefore, we reasoned that a screen for mutations that exhibit synthetic lethal interactions with cdc25-22 might uncover new genes that influence the mitotic control. These genes might encode elements of the Nim1 or Spc1 pathways or elements of undiscovered control processes. In this article we describe slm1, one of the first genes identified in this screen. We show that slm1 is identical to cdr2, a locus identified in a previous mutant screen (Young and Fantes, 1987) . We report that Cdr2 is a serine/ threonine protein kinase that shares homology to Nim1/Cdr1. Our studies suggest that Cdr2 modulates phosphorylation of Cdc2 on tyrosine-15. This control appears to be largely accomplished by regulation of Wee1, probably in a manner similar to Nim1/Cdr1.
MATERIALS AND METHODS

Yeast Strains and General Techniques
The S. pombe strains used in this study are listed in Table 1 . Yeast extract medium YES and synthetic minimal media EMM2 and SSA were used for growing yeast cells. Growth media and basic genetic and biochemical techniques for fission yeast have been described (Alfa et al., 1993) .
Isolation of Synthetic Lethal Mutants in a cdc25-22 Background
The cdc25-22 leu1-32 ura4-D18 strain (KS1483) was transformed with p25SS containing the cdc25 ϩ gene and the ura4 ϩ marker (Russell and Nurse, 1986). The resulting strain was mutagenized with N-methyl-NЈ-nitro-N-nitrosoguanidine at a level sufficient for 70% killing (Uemura and Yanagida, 1984) . Surviving cells were grown in EMM2 liquid media overnight and then incubated on a YES plate for 3 d at 25°C. The cells were replicated onto YES plates eight times and then onto YES plates containing 0.5 mg/ml 5-fluoroorotic acid. This screen identified 116 colonies that could not grow on 5-fluoroorotic plates.
Disruption of cdr2
For the first disruption construct, cdr2-D1 (see Figure 2A ), 5Ј and 3Ј flanking DNA fragments were amplified by PCR with two pairs of primers. The primers were JK18 (5Ј-TCTACTACTGAGCTCCAA-3Ј; SacI site underlined), JK19 (5Ј-CGCGGATCCCAAGGTC-CAACTTC-3Ј; BamHI site underlined), JK20 (5Ј-ACAGAATTC-CAGCTGATTT-3Ј; PvuII site underlined), and JK21 (5Ј-GATAAC-CTAGATATCCTAC-3Ј; EcoRV site underlined). Wild-type S. pombe genomic DNA was used as template. The amplified DNA fragments were cloned into pBlueScript SK (Stratagene, La Jolla, CA), and a 1.8-kb fragment of the ura4 ϩ cassette (Grimm et al., 1988) was inserted. The resultant plasmid was digested by SacI and XhoI to release the cdr2::ura4 ϩ fragment and then used to transform diploid cells. For the second disruption construct, cdr2-D2 (see Figure 2A) , a 1.7-kb EcoRI DNA fragment, resulting from the DNA amplified with a pair of primers JK59 and JK60 (see below), was cloned into pBlueScript SK and digested by PstI, and then a 1.8-kb fragment of the ura4 ϩ cassette was inserted. The resultant plasmid was digested by EcoRI, and the cdr2::ura4 ϩ fragment was used for transformation.
Chromosomal Integration of cdr2HA6H
To tag genomic cdr2 ϩ with a sequence encoding two copies of the HA epitope and hexahistidine at the carboxyl terminus, the cdr2 ϩ open reading frame (ORF) was amplified by PCR with primers JK103 (5Ј-GGAGGAGATCTTATGAGTACAATTTCAGAAGTTGG-3Ј; BglII site underlined) and JK104 (5Ј-AAATATGCGGCCG-CAACTTTGGACGGATTGTCGTTG-3Ј; NotI site underlined) and cloned into pRIP42-HA6H . After the nmt1 promoter was eliminated from the vector, the resultant plasmid was linearized at the XbaI site in cdr2 ϩ and used for transformation of wild-type (PR109) or cdc25-22 (JK1864) strains. Stable integration and tagging were confirmed by Southern blotting and immunoblotting. The function of Cdr2HA6H was confirmed by analysis of cell morphology.
Expression of GST-Cdr2 Fusion Protein in Fission Yeast
The cdr2 ϩ ORF was amplified by PCR with primers JK59 (5Ј-GCGCGCGGATCCTATGAGTACAATTTCAGAAGTTG-3Ј; BamHI site underlined) and JK60 (5Ј-GCGCGCGGATCCACGAGTATA-CATTATGTTCAATTA-3Ј; BamHI site underlined) and cloned into the BamHI sites of pJL205, which expresses GST fusion protein from the nmt1 promoter (Leatherwood et al., 1996) . Plasmids were transformed into S. pombe cells, and expression from the nmt1 promoter was induced by thiamine depletion (Maundrell, 1993) . GST fusion proteins were precipitated by using glutathione (GSH)-Sepharose 4B (Pharmacia, Uppsala, Sweden) as described . The cdr2-K39A mutation was made by sequential PCR mediated mutagenesis, changing codon 39 from AAA to GCT. After PCR, DNA sequencing confirmed that no additional mutations had been introduced.
Expression of GST-Wee1 Proteins in Bacteria
Construction of GST-Wee1(11-152) has been described previously (Boddy et al., 1998) . PCR fragments were made encoding amino acids 153-459 and 460 -877 of Wee1, incorporating a 5Ј NdeI site and a 3Ј NotI site. Those fragments were cloned into a modified pGEX vector and transformed into the Escherichia coli BL21 (DE3) . Preparation of GST-Wee1 proteins bound to GSH-Sepharose was performed as described previously (Boddy et al., 1998) .
Kinase Assays
GSH-Sepharose precipitates of GST-Cdr2 were washed three times with lysis buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 5 mM EDTA, 10% glycerol, 0.1% Nonidet P-40, 50 mM NaF, 0.1 mM Na 3 VO 4 supplemented with 1 mM phenylmethylsulfonyl fluoride and 5 g/ml aprotinin, leupeptin, and pepstatin). The GSH-Sepha- .5], 10 mM MgCl 2 , 10 mM MnCl 2 , 10 mM NaF, 0.1 mM Na 3 VO 4 , 1 mM DTT). The bound complexes were resuspended in 50 l of kinase buffer containing 50 M [␥-32 P]ATP, 100 M to 1.5 mM ATP, and 10 mM glutathione. The reaction was incubated at 30°C for 30 min. After the incubation, 50 l of Laemmli sample buffer was added, samples were boiled for 2 min, and then half of each reaction was analyzed by SDS-PAGE.
RESULTS
Isolation of Mutations That Are Synthetic Lethal with cdc25-22
To identify novel mitotic control genes, we screened for synthetic lethal mutations (slm) in a cdc25-22 background at 25°C. A cdc25-22 strain was transformed with a plasmid (p25SS) containing the cdc25 ϩ gene and then mutagenized with N-methyl-NЈ-nitro-N-nitrosoguanidine. Among 76,500 mutagenized cells, we isolated 116 mutants that were dependent on p25SS for growth on complete YES medium at 25°C. Eleven of these strains underwent dramatic cell elongation or cell cycle arrest when p25SS was lost (Figure 1 ). Genetic analysis established that three mutations resided in nim1 and one mutation resided in wis1. The other mutations appear to occur in seven other genes. In this article we describe one of these genes, slm1.
The slm1 Gene Is Identical to cdr2
We were unable to clone slm1 ϩ by complementation of the cdc25-22 slm1-1 synthetic lethal phenotype, so instead we used positional cloning. Mitotic haploidization showed that slm1 mapped to chromosome I. Genetic linkage analysis indicated that slm1 was located 9.3 cM to the right of cut9. This site was predicted to lie within the genomic DNA fragment cloned in 57a10, a cosmid sequenced as part of the S. pombe genome sequencing project at the Sanger Centre (Cambridge, UK). P87050, an ORF in 57a10, rescued slm1-1 (our unpublished data). The ura4 ϩ marker was used to create disruption and deletion mutations of P87050 in diploid strains (Figure 2A ). The resulting heterozygous Ura ϩ diploid cells produced four viable spores that segregated 2:2 for uracil prototrophy, indicating that P87050 was not essential. Genetic crosses established that P87050 and slm1 were tightly linked. Furthermore, mating of the P87050 disruptant strain to the cdc25-22 mutant yielded tetratype tetrads in which one of the two Ura ϩ spores germinated to produce cells that appeared identical to the original cdc25-22 slm1-1 cells. These data supported the conclusion that the P87050 ORF is indeed slm1.
In the process of analyzing slm1, we found that it is identical to the cdr2 gene (Kathy Gould, personal communication). The cdr2 mutant was originally isolated as a mutant that failed to arrest division at a small size in response to nitrogen starvation (Young and Fantes, 1987) . The cdr2 mutant cells are longer than wild-type cells, and the cdr2-97 cdc25-22 double mutant is highly elongated at 20°C and cannot grow at 27°C. Hereafter we shall refer to slm1 as cdr2.
Cdr2 Is a Novel Serine/Threonine Protein Kinase Related to Nim1/Cdr1
The cdr2 gene encodes a novel protein of 775 amino acids with a predicted molecular weight of ϳ86 kDa. Cdr2 protein contains a serine/threonine kinase motif in the N-terminus region. The deduced amino acid sequence of Cdr2 was compared with databases. It showed substantial similarity to Saccharomyces cerevisiae Gin4p (Akada et al., 1997; Altman and Kellogg, 1997) and S. pombe Nim1/Cdr1 ( Figure 2B ). These proteins belong to the SNF1 serine/threonine kinase family. The S. cerevisiae GIN4 gene was first isolated as a growth inhibitory gene, but it recently has been shown that GIN4 is not essential and physically interacts with Cdc28p complex (Okuzaki et al., 1997 ). Another budding yeast homolog of Nim1, NIK1/HSL1, is thought to be a negative regulator of the SWE1 kinase, a homolog of fission yeast Wee1 (Ma et al., 1996; Tanaka and Nojima, 1996) . DNA sequence analysis revealed that the cdr2-1 allele changes a glycine codon to aspartic acid at position 186 in subdomain IX. Glycine-186 is conserved among Cdr2, Nim1/Cdr1, Gin4p, and Nik1/Hsl1. disruptant cells were elongated at division compared with wild-type cells in both rich YES and synthetic EMM2 media. These haploid cells had a 2C DNA content, indicating a G2 cell cycle delay ( Figure 3B ). Some mutants that undergo mitosis at an elongated cell length are defective at arresting in G1 phase when starved of nitrogen, probably because of the problem with G2-M cell size control. We determined whether the cdr2 disruptant had a G1 arrest when starved of nitrogen. The cdr2 and control cells were cultured to midlog phase in EMM2 medium, transferred to nitrogen-free EMM2 medium (EMM2-N), and then subjected to flow cytometry analysis of DNA content. Most of the wild-type cells arrested in G1 with a 1C DNA content after 24 h incubation in EMM2-N medium ( Figure 3B ). The nim1 disruptant cells had a defect in response to nitrogen starvation, but they eventually arrested as small cells in G1 phase after 24 h starvation ( Figure 3, A and B) ; however, most of the cdr2 cells had a 2C DNA content even 24 h after nitrogen starvation, and they were substantially larger than wild-type cells (Figure 3, A and B) . Although the optical density of the cdr2 and the wild-type cultures increased to similar extents, the final cell number in the cdr2 culture was approximately half the amount of the culture of wild-type cells ( Figure 3C ). The nitrogen-starved cdr2 cells were uninucleate and acquired resistance to heat shock (our unpublished data), suggesting that the cdr2 cells enter a quiescent state from G2 instead of G1. These data suggest that the G2-M size control defect caused the cdr2 cells to fail to arrest in G1 when starved of nitrogen.
The Amount of Cdr2 Protein Decreases in Nitrogenstarved Cells
To determine whether the expression of cdr2 ϩ is regulated during the cell cycle, we first measured the abundance of cdr2 ϩ mRNA. Cells were synchronized by a cdc25-22 block and release protocol, which arrests cells in late G2 phase by incubating at the restrictive temperature of 35.5°C and then induces them to enter M-phase synchronously by shifting the culture to the permissive temperature of 25°C. The cdr2 ϩ mRNA was detected at all time points, and no significant periodic change could be seen ( Figure 4A ). Cell cycle periodicity was confirmed by the oscillation of the cdc22 ϩ mRNA signal that appears during S phase (Lowndes et al., 1992 ). We also examined the level of cdr2 ϩ mRNA in nitrogen-starved cells. The cdr2 ϩ mRNA signal was unchanged during the course of nitrogen starvation ( Figure 4B ). We next determined the amount of Cdr2 protein using strains in which the single chromosomal copy of cdr2 ϩ was tagged with a sequence encoding two copies of HA epitope and six consecutive histidine residues. A cdc25-22 block and release protocol synchronized cells, and whole-cell extracts of each sample were used for the detection of Cdr2-HA protein by immunoblotting. Cdr2-HA protein was detected as a band of ϳ85 kDa. Cdr2 protein was present throughout the cell cycle, with no significant change in abundance ( Figure 5A ). In contrast, the amount of Cdr2 protein dramatically changed in nitrogen-starved cells. The Cdr2 signal dropped to an undetectable level within 3 h after nitrogen starvation ( Figure 5B ). The cell morphology of wildtype (PR109), ⌬nim1 (LW1817), ⌬cdr2 (JK2240), and ⌬cdr2 ⌬nim1 (JK2241) strains. Cells were grown in EMM medium to the log phase (ϩN) and then shifted to nitrogen-free EMM medium and incubated for 24 h (ϪN) at 30°C. Photographs were taken under the Nomarski differential interference microscope. Bar, 10 m. (B) Flow cytometric analyses of DNA content each strain. Cells were harvested at indicated intervals after nitrogen starvation and subjected to flow cytometry. (C) Increase of OD 600 of the cultures of wild-type (PR109) and ⌬cdr2 (JK2240) strains after nitrogen starvation (top panel). Cells were treated as described above. Bottom panel shows increase of the cell number of each strain after nitrogen starvation. These properties of Cdr2 are similar to those of Nim1 (Wu et al., 1996; Wu and Russell, 1997b) .
Genetic Studies Suggest That Cdr2 Regulates Phosphorylation of Cdc2 on Tyrosine-15
To investigate the basis of the cdr2 cell elongation phenotype, we transformed cdr2 cells with the pREP3-cdc25 plasmid. This plasmid contains cdc25 ϩ regulated by the nmt1 promoter. Overexpression of cdc25 ϩ rescued the cell elongation phenotype of cdr2, indicating that cdr2 regulates the activity of Cdc2 directly or indirectly ( Figure 6A ). This supposition was supported by the observation that a wee1 mutation suppresses the cdr2 cdc25-22 synthetic lethality at 25°C. Double-mutant cdc25-22 wee1-50 cells are viable at the restrictive temperature of 35°C, because the wee1-50 mutation bypasses the requirement for Cdc25 activity. Triple mutant cdr2 cdc25-22 wee1-50 cells also grew well at 35°C ( Figure 6B ). In fact, at 35°C these cells were indistinguishable from cdc25-22 wee1-50 cells ( Figure 6C ). Thus, loss of Cdr2 apparently has no effect in cells that lack Cdc25 and Wee1 activity. These findings are reminiscent of the effect of the nim1 mutation in cdc25-22 wee1-50 cells. Deletion of nim1 has no effect in cdc25-22 wee1-50 cells incubated at 35°C. These findings contrast with the effect of the spc1 mutation or some of the other slm mutations such as slm9. Loss of Spc1 activity causes cell-cycle arrest in cdc25-22 wee1-50 cells incubated at 35°C . A very similar effect was seen with the slm9 mutation ( Figure 6 , B and C).
Cdc25 Is Not the Primary Target of Cdr2
These data suggested that the G2 delay caused by cdr2 deletion might involve the regulation of tyrosine-15 phosphorylation of Cdc2. We performed two experi- ments to evaluate whether Cdr2 was regulating Cdc25 activity. In the first experiment we examined the phenotype of the ⌬cdr2 cdc2-3w ⌬cdc25 strain. The cdc2-3w mutation activates Cdc2, thereby bypassing the requirement for Cdc25. If Cdr2 functions exclusively to activate Cdc25, we would expect the cdr2 mutation to have no effect in a cdc2-3w ⌬cdc25 background; however, we observed that the ⌬cdr2 cdc2-3w ⌬cdc25 cells were elongated relative to cdc2-3w ⌬cdc25 cells ( Figure 7A ). These data indicate that Cdr2 regulates cell size at division in the absence of Cdc25 activity. In the second experiment we measured the effect of the cdr2 deletion on the rate of induction of mitosis after inactivation of Wee1 and Mik1. This experiment used a wee1-50 ⌬mik1 strain that lacked Mik1 and expressed temperature-sensitive Wee1 protein. Cells with the wild-type cdr2 ϩ or mutant ⌬cdr2 allele were synchronized in G2 by centrifugal elutriation and then shifted from 25 to 35°C. In this experiment the rate of division after the temperature shift is determined by the amount of Cdc25 activity . We found that cdr2 ϩ and mutant ⌬cdr2 cells underwent division at equal rates ( Figure 7B ). These data argue strongly that Cdr2 does not regulate Cdc25 activity.
Genetic Studies Suggest That Cdr2 Regulates Wee1
The high sequence homology between Cdr2 and Nim1 suggested that the two protein kinases might have similar functions. If this hypothesis were true we would expect that cdr2 and nim1 mutations should have additive effects. This hypothesis was confirmed in the nitrogen starvation experiment that showed that the ⌬cdr2 ⌬nim1 double mutant was longer than either single mutant ( Figure 3A) . The G1 arrest defect was also more severe in the double mutant ( Figure 3B ). The cell elongation and G2 delay caused by the nim1 mutation is completely suppressed by wee1-50, a finding that supports the conclusion that Nim1 acts solely as an inhibitor of Wee1. In view of the similarity between Nim1 and Cdr2, we tested whether the cdr2 phenotype is suppressed by the temperature-sensitive wee1-50 mutation. We observed that ⌬cdr2 wee1-50 cells were slightly elongated at the permissive temperature of 25°C. The ⌬cdr2 wee1-50 cells became much smaller at the restrictive temperature of 35°C, showing that the ⌬cdr2 cell elongation phenotype was fully suppressed by inactivation of Wee1 protein (Figure 8 ). These data indicate that Wee1 is likely to be the main target of Cdr2.
Autophosphorylation of Cdr2 Protein
To characterize Cdr2 protein, a protein kinase assay of GST-Cdr2 purified from fission yeast was performed. K39A , in which the lysine-39 residue in the kinase domain is changed to alanine, was made to ϩ encodes an HA epitope-tagged form of Cdr2 at the carboxyl terminus, was grown in EMM medium to midlog phase, and cells were synchronized as described in Figure 4 . Samples were taken every 20 min after the shift to permissive temperature, and whole-cell extracts were prepared. Immunoblotting was performed with anti-HA antibodies for Cdr2-HA protein and with anti-PSTAIRE antibodies for Cdc2 protein (control). (B) Strain JK2310 (h Ϫ cdr2HA6H) was grown to midlog phase in EMM2 and then resuspended in EMM2-N. Samples were taken at intervals after nitrogen starvation.
inactivate kinase activity of Cdr2 protein. The kinase activity of GST-Cdr2 K39A was substantially diminished relative to wild-type GST-Cdr2 ( Figure 9A ). In these assays, both autophosphorylation and phosphorylation of the myelin basic protein were greatly decreased in the GST-Cdr2 K39A samples. These findings were reflected in studies of GST-Cdr2 phosphorylation in vivo. As assayed by immunoblotting, GSTCdr2 migrated as a diffuse protein that had a slower mobility than GST-Cdr2
K39A
. After treatment with calf intestinal alkaline phosphatase (CIAP), GST-Cdr2 migrated as a less diffuse band that had the same mobility as GST-Cdr2 K39A ( Figure 9B ). These data indicate that GST-Cdr2 autophosphorylates in vivo. The fact that some kinase activity was detected when we used GST-Cdr2 K39A suggests that GST-Cdr2 K39A is not fully kinase deficient or that some Cdr2-associated kinases exist.
Cdr2 Binds and Phosphorylates N-Terminus of Wee1
In Vitro Genetic analyses indicated that Cdr2 regulates Wee1. Experiments were performed to explore whether Cdr2 is able to interact directly with Wee1. Lysates from cells in which genomic cdr2 was tagged with two copies of HA at the C-terminal end of ORF were prepared, incubated with GST-Wee1 or GST proteins, washed, and analyzed by immunoblotting ( Figure  10A ). Cdr2-HA protein was precipitated specifically with GST-Wee1(11-152), which contains amino acids 11-152 of Wee1. Next, we performed an in vitro kinase assay using GST-Wee1(11-152) as a substrate. GSTCdr2 protein, but not GST-Cdr2 K39A , efficiently phosphorylated GST-Wee1(11-152) in vitro ( Figure 10B,  lanes 1-3) . Interestingly, GST-Cdr2 did not phosphorylate GST-Wee1 70 , a truncation product of GSTWee1(11-152), whereas GST-Cds1 did ( Figure 10B , lane 4). Cds1 protein kinase was shown to bind and phosphorylate GST-Wee1(1-72) in vitro after treatment with hydroxyurea (Boddy et al., 1998) . These data indicate that Cdr2 and Cds1 phosphorylate different sites of Wee1 in vitro.
DISCUSSION
In this article we have presented the discovery and initial analysis of cdr2 ϩ , a new gene that appears to be involved in the regulation of mitosis in fission yeast. Loss of Cdr2 activity causes cells to grow to a larger cell size before initiating cell division. These findings suggest that Cdr2 has a positive role in the induction of mitosis. Consistent with this notion, we discovered cdr2-1 as a mutation that causes cell-cycle arrest when the activity of Cdc25 is reduced by the cdc25-22 mutation. These phenotypes are highly reminiscent of the effects of nim1/cdr1 mutations (Russell and Nurse, 1987b; Feilotter et al., 1991; Wu and Russell, 1993) . Like nim1/cdr1 mutations, cdr2 mutations are suppressed by wee1 mutations and appear to have no effect in a wee1-50 cdc25-22 background. The latter property distinguishes nim1/cdr1 and cdr2 mutations from mutations in the Spc1/StyI stress-activated kinase cascade, which cause cell-cycle arrest in a wee1-50 cdc25-22 background. The similarities between the phenotypes caused by nim1/cdr1 and cdr2 mutations are even more striking when one realizes that Cdr2 and Nim1/Cdr1 are closely related members of the serine/threonine protein kinase family. Genetic epistasis studies indicate that Cdr2 and Nim1/Cdr1 function indepen- dently because the phenotypes of nim1/cdr1 and cdr2 mutations are additive.
A combination of genetic and biochemical studies has shown that Nim1/Cdr1 directly inhibits Wee1. Details of the mechanism are lacking, but it is well established that Nim1/Cdr1 inhibits Wee1 in an in vitro assay that uses purified proteins (Coleman et al., 1993; Parker et al., 1993; Wu and Russell, 1993) . The similar genetic properties of nim1/cdr1 and cdr2 mutations, coupled with the sequence homology of Cdr2 and Nim1/Cdr1 proteins, strongly suggest that the two protein kinases function by similar mechanisms. A priority in future studies will be to formally establish that Cdr2 directly inhibits Wee1. Alternatives include the possibility that Cdr2 indirectly regulates Wee1, perhaps by phosphorylating Nim1/Cdr1, or that Cdr2 regulates Mik1, Cdc25, or Pyp3. In theory, the first possibility could be determined by examining the effect of Cdr2 overproduction in a nim1/cdr1 mutant, but there are difficulties with this experiment that are discussed below. If Cdr2 acted primarily by inhibiting Mik1, then we would expect that the cdr2 cell elongation phenotype would be suppressed by an mik1 mutation; however, the cdr2 cell elongation phenotype is not dependent on Mik1. Thus it appears that Mik1 is not a major target of Cdr2. The possibility that Cdr2 is an activator of Cdc25 also appears to be unlikely. Loss of Cdr2 activity delays mitosis in strains that have no active Cdc25 protein (i.e., cdc2-3w ⌬cdc25). Therefore we can certainly conclude that Cdc25 is not the primary target of Cdr2 regulation. This conclusion is supported further by the observation that a cdr2 mutation does not delay mitosis after inactivation of Wee1 protein in a ⌬mik1 background. The fourth possibility is that Cdr2 is required for Pyp3 activity; however, this proposition appears unlikely to be correct because loss of Pyp3 has very little effect on cell size in a wild-type background (Millar et al., 1992) . Moreover, Pyp3 activity is crucial for viability in a wee1-50 ⌬cdc25 strain, whereas cdr2 mutations have no effect in this strain background.
The idea that Cdr2 targets Wee1 is also supported by in vitro biochemical studies. We have found that Cdr2 physically interacts with and phosphorylates the N-terminal domain of Wee1 in vitro. Specifically, we found that Cdr2 phosphorylates a GST fusion protein containing amino acids 11-152 of Wee1, but not the 11-70 region. In a previous study we found that Cds1, a protein kinase that is activated by the DNA replication checkpoint that prevents mitosis, also associates with the N-terminus of Wee1 in cell lysates (Boddy et al., 1998) . These studies showed that Cds1 phosphorylates the 11-70 region of Wee1. Thus Cdr2 and Cds1 phosphorylate different regions of Wee1. Interestingly, the previous studies of Cds1 also revealed that in cell lysates another protein kinase (or kinases) associates with and phosphorylates the 11-152 region of Wee1, but not the 11-70 region. Moreover, this activity of this unknown kinase appears to increase at or shortly before mitosis. This pattern of activation suggests that this kinase might have a role in a feedback loop in which Cdc2 catalyzes its own activation by inhibiting Wee1 directly or indirectly. This model is consistent with studies that have shown that deletion of the N-terminal region of Wee1 causes cell elongation (Aligue et al., 1997) . Thus, the N-terminus of Wee1 possibly has the inhibitory effect on Wee1 activity. The unknown kinase that is specific for the 70 -152 region of Wee1 is not Cdc2 (Boddy and Russell, unpublished studies) , but Cdc2 might regulate the kinase. It will be of interest to determine whether Cdr2 contributes to this activity.
Overall, genetic and biochemical studies support the idea that Nim1/Cdr1 and Cdr2 function by similar mechanisms. There is, however, one important difference between Nim1/Cdr1 and Cdr2. Overproduction of Nim1/Cdr1 causes a wee phenotype, exactly as expected for a rate-limiting inhibitor of Wee1 (Russell and Nurse, 1987b) . In contrast, overproduction of Cdr2, even at a relatively moderate level, is toxic (our unpublished data). This fact probably explains why we were unable to clone cdr2 ϩ by functional complementation from libraries made with multi-copy plasmids. Overproduction of Cdr2 causes cells to elongate and form multiple division plates. This result might be taken as evidence against a mechanism in which Cdr2 inhibits Wee1, but the interpretation of the Cdr2 over- Figure 8 . Inactivation of Wee1 fully suppresses the cell elongation phenotype caused by the ⌬cdr2 mutation. Wild-type (PR109) and ⌬cdr2 (JK2240) strains were grown in EMM2 media at 30°C (top panels). The wee1-50 (JM298) and ⌬cdr2 wee1-50 (JK2242) strains were grown in EMM media at 20°C to log phase (middle panels) and then shifted to 35°C for 15 h (bottom panels). Bar, 10 m. Numbers in panels refer to cell length at division. GST-Cdr2 appears to undergo autophosphorylation in vivo. (A) Wild-type strain transformed with pJL205-cdr2 or pJL205-cdr2 K39A was grown in the absence of thiamine, and the cell extracts were prepared. GST fusion proteins were precipitated by using GSH-Sepharose and assayed for kinase activity in the presence of myelin basic protein (MBP). Anti-GST immunoblotting shows that approximately equal amounts of GST-Cdr2 protein were used in this assay (bottom panel). (B) Phosphatase treatment causes a mobility shift of GST-Cdr2. Cell extracts of asynchronous wild-type cells carrying pJL205-cdr2 or pJL205-cdr2 K39A were prepared, and GST fusion proteins were precipitated by using GSH-Sepharose and subjected to calf intestinal alkaline phosphatase (CIAP) treatment. Lane 1, wild-type Cdr2 with no CIAP treatment; lane 2, Cdr2 K39A with no CIAP; lane 3, wild-type Cdr2 with CIAP; lane 4, wild-type Cdr2 with CIAP and phosphatase inhibitors. Western blotting with antibodies to GST is shown.
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Vol. 9, December 1998production phenotype is complicated. We observed that overproduction of a kinase inactive version of Cdr2 also caused the same phenotype. In fact, the Cdr2 K39A protein appeared to be undiminished in its ability to cause cell elongation. We cannot be certain that Cdr2
K39A protein was without kinase activity, but our in vitro kinase assays demonstrated that the kinase activity of Cdr2 K39A was substantially decreased relative to wild-type Cdr2. Moreover, Cdr2
K39A protein was clearly defective at promoting autophosphorylation in vivo. These findings suggest that cell elongation caused by overproduction of Cdr2 is not due to increased phosphorylation of its substrate. It is plausible that Wee1 was inhibited by overproduction of Cdr2 but that this phenotype was obscured by a kinase-independent effect caused by Cdr2 overproduction. At this point we do not know whether the Cdr2 overproduction phenotype is indicative of Cdr2 having a substrate other than Wee1 or whether Cdr2 interacts with another protein that is not a substrate but is important for cell division. Of course, it is possible that the Cdr2 overproduction phenotype is an artifact in the true sense of the word.
In summary, our studies indicate that the protein kinase Cdr2 has a positive regulatory influence on mitotic control. Genetic findings argue strongly against the possibility that Cdr2 regulates Mik1, Cdc25, or Pyp3, but they are fully consistent with a model in which Cdr2 regulates Wee1 in a negative manner. This model is further supported by studies showing that Cdr1 associates with Wee1 in cell lysates and phosphorylates Wee1 in vitro. Future studies will be aimed at determining whether Wee1 is a physiologically significant substrate of Cdr2.
